Abstract：
BACKGROUND: The COVID-19 pandemic has instigated the development of telemedicine-mediated provision of medications for opioid use disorder such as buprenorphine and methadone, referred to as TMOUD in this study. As services start to return to pre-pandemic norms, there is a debate around the role of TMOUD as addition to or replacement of the conventional cascade of care for people with opioid use disorder (PWOUD). This scoping review is designed to characterize existing TMOUD services and provide insights to enable a more nuanced discussion on the role of telemedicine in the care of PWOUD.
METHODS: The literature search was conducted in OVID Medline, CINAHL, and PsycINFO, from inception up to and including April 2023, using the Joanna Briggs Institute methodology for scoping reviews. The review considered any study design that detailed sufficient descriptive information on a given TMOUD service. A data extraction form was developed to collect and categorize a range of descriptive characteristics of each discrete TMOUD model identified from the obtained articles.
RESULTS: A total of 45 articles met the inclusion criteria, and from this, 40 discrete TMOUD services were identified. In total, 33 services were US-based, three from Canada, and one each from India, Ireland, the UK, and Norway. Through a detailed analysis of TMOUD service characteristics, four models of care were identified. These were TMOUD to facilitate inclusion health, to facilitate transitions in care, to meet complex healthcare needs, and to maintain opioid use disorder (OUD) service resilience.
CONCLUSIONS: Characterizing TMOUD according to its functional benefits to PWOUD and OUD services will help support evidence-based policy and practice. Additionally, particular attention is given to how digital exclusion of PWOUD can be mitigated against.
METHODS: The literature search was conducted in OVID Medline, CINAHL, and PsycINFO, from inception up to and including April 2023, using the Joanna Briggs Institute methodology for scoping reviews. The review considered any study design that detailed sufficient descriptive information on a given TMOUD service. A data extraction form was developed to collect and categorize a range of descriptive characteristics of each discrete TMOUD model identified from the obtained articles.
RESULTS: A total of 45 articles met the inclusion criteria, and from this, 40 discrete TMOUD services were identified. In total, 33 services were US-based, three from Canada, and one each from India, Ireland, the UK, and Norway. Through a detailed analysis of TMOUD service characteristics, four models of care were identified. These were TMOUD to facilitate inclusion health, to facilitate transitions in care, to meet complex healthcare needs, and to maintain opioid use disorder (OUD) service resilience.
CONCLUSIONS: Characterizing TMOUD according to its functional benefits to PWOUD and OUD services will help support evidence-based policy and practice. Additionally, particular attention is given to how digital exclusion of PWOUD can be mitigated against.
摘要：
背景：COVID-19大流行促使了远程医疗介导的为阿片类药物使用障碍提供药物的发展，例如丁丙诺啡和美沙酮，在这项研究中被称为TMOUD。随着服务开始恢复到大流行前的规范，关于TMOUD作为阿片类药物使用障碍(PWOUD)患者常规级联护理的补充或替代作用存在争议.此范围审查旨在表征现有的TMOUD服务，并提供见解，以就远程医疗在PWOUD护理中的作用进行更细致的讨论。
方法：文献检索在OVIDMedline，CINAHL,和PsycINFO,从成立到2023年4月，使用乔安娜·布里格斯研究所的方法进行范围审查。该审查考虑了任何研究设计，该设计详细说明了有关给定TMOUD服务的足够描述性信息。开发了数据提取表格，以收集和分类从获得的文章中识别出的每个离散TMOUD模型的一系列描述性特征。
结果：共有45篇文章符合纳入标准，由此，确定了40个离散的TMOUD服务。总的来说,33个服务是基于美国的，三个来自加拿大,每个来自印度，爱尔兰,英国,挪威。通过对TMOUD服务特点的详细分析,确定了四种护理模式.这些是TMOUD，以促进包容性健康，为了促进护理过渡，为了满足复杂的医疗保健需求，并保持阿片类药物使用障碍(OUD)服务的弹性。
结论：根据其对PWOUD和OUD服务的功能优势来表征TMOUD将有助于支持基于证据的政策和实践。此外,特别注意如何减轻PWOUD的数字排除。
方法：文献检索在OVIDMedline，CINAHL,和PsycINFO,从成立到2023年4月，使用乔安娜·布里格斯研究所的方法进行范围审查。该审查考虑了任何研究设计，该设计详细说明了有关给定TMOUD服务的足够描述性信息。开发了数据提取表格，以收集和分类从获得的文章中识别出的每个离散TMOUD模型的一系列描述性特征。
结果：共有45篇文章符合纳入标准，由此，确定了40个离散的TMOUD服务。总的来说,33个服务是基于美国的，三个来自加拿大,每个来自印度，爱尔兰,英国,挪威。通过对TMOUD服务特点的详细分析,确定了四种护理模式.这些是TMOUD，以促进包容性健康，为了促进护理过渡，为了满足复杂的医疗保健需求，并保持阿片类药物使用障碍(OUD)服务的弹性。
结论：根据其对PWOUD和OUD服务的功能优势来表征TMOUD将有助于支持基于证据的政策和实践。此外,特别注意如何减轻PWOUD的数字排除。
